Literature DB >> 12948461

Intraoperative monitoring of cochlear nerve compound action potential in cerebellopontine angle tumour removal.

Iwao Yamakami1, Nobuo Oka, Akira Yamaura.   

Abstract

Cochlear nerve compound action potential (CNAP) provides a real-time auditory evoked potential. Because of technical difficulty, CNAP monitoring has not been popular during the removal of cerebellopontine angle (CPA) tumour. To clarify the efficiency of intraoperative CNAP monitoring, we designed an intracranial electrode for CNAP monitoring and performed the simultaneous monitoring of CNAP and auditory brainstem response (ABR) in 10 patients undergoing CPA tumour removal in an attempt to preserve hearing. ABR recordings during microsurgical tumour removal were unsatisfactory in 6 patients because of severe artifacts. Reliable CNAP recordings were obtained without artifacts in all 10 patients throughout surgery. Eight patients preserved useful hearing after tumour removal, and the CNAP amplitude reflected the postoperative hearing. The newly designed intracranial electrode enables CNAP monitoring predicting the postoperative hearing more reliably than ABR. CNAP monitoring is efficient to improve the hearing preservation rate following CPA tumour removal.

Entities:  

Mesh:

Year:  2003        PMID: 12948461     DOI: 10.1016/s0967-5868(03)00143-7

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Neuromonitoring of cochlea and auditory nerve with multiple extracted parameters during induced hypoxia and nerve manipulation.

Authors:  Jorge Bohórquez; Ozcan Ozdamar; Krzysztof Morawski; Fred F Telischi; Rafael E Delgado; Erdem Yavuz
Journal:  J Neural Eng       Date:  2005-03-08       Impact factor: 5.379

2.  Clinical features of intracranial vestibular schwannomas.

Authors:  Xiang Huang; Jian Xu; Ming Xu; Liang-Fu Zhou; Rong Zhang; Liqin Lang; Qiwu Xu; Ping Zhong; Mingyu Chen; Ying Wang; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2012-10-31       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.